Novel keratoconus biomarker

Novel keratoconus biomarker
Dermot McGrath
Dermot McGrath
Published: Sunday, June 28, 2020
Jesper Hjortdal MD,PhD
Progress is being made on several fronts to advance understanding of the complex pathogenesis of keratoconus, including identification of a novel biomarker that may prove useful as a supplemental diagnostic test for the disease, according to Jesper Hjortdal MD, PhD. “Keratoconus remains an elusive disease where differentiation between association, cause, and effect is challenging and varies between individuals. Our research has identified a potential biomarker called Prolactin-Induced Protein (PIP), which seems to influence enzymes affecting corneal structure and homeostasis,” he said in a presentation at the World Ophthalmology 2020 Virtual Congress. Studies have shown that saliva, tears and serum samples reveal hormone imbalances in keratoconus patients, explained Prof. Hjortdal. “We are intrigued by the versatile function of PIP and the fact that it is regulated profoundly in keratoconus patients. The clinical significance of these observations is important and targeting PIP directly or indirectly may prove effective not only in early disease stages but also in advanced keratoconus stages,” he said. Using PIP as a biomarker for keratoconus and/or a therapeutic target would represent a significant paradigm shift in keratoconus research, added Prof. Hjortdal. He added that a lot of progress has also been made in epidemiological studies carried out in Denmark in recent years. “We know for instance that non-Europeans have more than threefold higher odds of keratoconus compared to Europeans, and that atopic dermatitis. allergic rhinitis and asthma are common among patients with keratoconus. The good news, however, is that keratoconus is not associated with higher mortality in Denmark,” he said.  
Tags: keratoconus biomarker
Latest Articles
Simulators Benefit Surgeons and Patients

Helping young surgeons build confidence and expertise.

Read more...

How Many Surgeries Equal Surgical Proficiency?

Internet, labs, simulators, and assisting surgery all contribute.

Read more...

Improving Clinical Management for nAMD and DME

Global survey data identify barriers and opportunities.

Read more...

Are Postoperative Topical Antibiotic Drops Still Needed?

Cataract surgeons debate the benefits of intracameral cefuroxime prophylaxis.

Read more...

Emerging Technology for Detecting Subclinical Keratoconus

Brillouin microscopy shows promise in clinical studies.

Read more...

Knowing Iris Repair: Modified Trifold Technique

Part eight of our series covers the modified trifold technique for large iris defects.

Read more...

It’s All About Biomechanics!

Increasing the pool of patients eligible for refractive surgery.

Read more...

Uncovering More Safe and Quick Options

Different strategies, such as PresbyLASIK, can offer presbyopes good outcomes.

Read more...

Topography-Guided PRK for Keratoconus

Improving visual acuity in patients with keratoconus.

Read more...

Defining AMD Treatment Protocol

Treatments trending to fewer injections for better results.

Read more...